nicotinamide
Niacinamide
What stands out in the reports.
ROR = reporting odds ratio (log scale). A value above 1 means the symptom is reported more often for this product than for all other products combined. This measures how much it stands out in reports — not cause, not risk.
Nicotinamide reports show disproportionately high reporting for 'OFF LABEL USE', 'PAIN IN EXTREMITY', 'OSTEOARTHRITIS', 'NIGHT SWEATS', 'NAUSEA', 'SYSTEMIC LUPUS ERYTHEMATOSUS', 'INFUSION RELATED REACTION', and 'PYREXIA'. While nausea and pyrexia (fever) might relate to general drug reactions, the other signals like osteoarthritis or lupus are not directly linked to nicotinamide's known actions. This suggests these effects are reported more often than expected, but 'frequently reported' is not the same as 'frequently caused'. This does not replace medical advice.
This does not replace medical advice.
No signals currently mapped to the label.
Report volume per quarter.
| Date | Class | Reason | Firm |
|---|---|---|---|
| Jul 18, 2025 | II | Lack of Processing Controls. | AEQUITA PHARMACY |
| Jul 18, 2025 | II | Lack of Processing Controls. | AEQUITA PHARMACY |
| Jul 18, 2025 | II | Lack of Processing Controls. | AEQUITA PHARMACY |
| Jul 18, 2025 | II | Lack of Processing Controls. | AEQUITA PHARMACY |
| Jul 18, 2025 | II | Lack of Processing Controls. | AEQUITA PHARMACY |
| Jul 18, 2025 | II | Lack of Processing Controls. | AEQUITA PHARMACY |
| Jul 18, 2025 | II | Lack of Processing Controls. | AEQUITA PHARMACY |
| Nov 22, 2023 | II | Presence of Particulate Matter. | AnazaoHealth Corporation |
| Dec 22, 2022 | II | Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility. | Pharmacy Innovations |
| Dec 22, 2022 | II | Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility. | Pharmacy Innovations |
| May 24, 2022 | II | Lack of Assurance of Sterility | US Specialty Formulations LLC |
| May 9, 2022 | II | Lack of assurance of sterility. | Olympia Compounding Pharmacy dba Olympia Pharmacy |
| May 9, 2022 | II | Lack of assurance of sterility. | Olympia Compounding Pharmacy dba Olympia Pharmacy |
| Jun 19, 2019 | II | Lack of Assurance of Sterility | RXQ Compounding LLC |
| May 23, 2019 | II | Lack of Sterility Assurance. | Pharm D Solutions, LLC |
| Dec 17, 2018 | II | Lack of sterility assurance. | Promise Pharmacy, LLC |
| Dec 17, 2018 | II | Lack of sterility assurance. | Promise Pharmacy, LLC |
| Dec 17, 2018 | II | Lack of sterility assurance. | Promise Pharmacy, LLC |
| Dec 17, 2018 | II | Lack of sterility assurance. | Promise Pharmacy, LLC |
| Feb 10, 2017 | II | Lack of Assurance of Sterility: There are also CGMP Deviations. | Synergy Rx |
| Feb 10, 2017 | II | Lack of Assurance of Sterility: There are also CGMP Deviations. | Synergy Rx |
| Feb 10, 2017 | II | Lack of Assurance of Sterility: There are also CGMP Deviations. | Synergy Rx |
| Nov 17, 2016 | II | Lack of Assurance of Sterility | Tri-Coast Pharmacy |
| Nov 17, 2016 | II | Lack of Assurance of Sterility | Tri-Coast Pharmacy |
| Nov 17, 2016 | II | Lack of Assurance of Sterility | Tri-Coast Pharmacy |
| Nov 17, 2016 | II | Lack of Assurance of Sterility | Tri-Coast Pharmacy |
| Nov 17, 2016 | II | Lack of Assurance of Sterility | Tri-Coast Pharmacy |
| Nov 17, 2016 | II | Lack of Assurance of Sterility | Tri-Coast Pharmacy |
| Nov 17, 2016 | II | Lack of Assurance of Sterility | Tri-Coast Pharmacy |
| May 13, 2016 | II | Lack of Assurance of Sterility | Medaus, Inc. |
Class I = reasonable probability of serious harm · Class II = temporary or reversible · Class III = unlikely to cause harm. Source: openFDA enforcement.